HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fischbein, M. P. Articles by Bonavida, B. Search for Related Content PubMed PubMed Citation Articles by Fischbein, M. P. Articles by Bonavida, B.

CD40 Signaling Replaces CD4⁺ Lymphocytes and Its Blocking Prevents Chronic Rejection of Heart Transplants

Michael P. Fischbein^*,, Abbas Ardehali, James Yun^,, Stephen Schoenberger^§, Hillel Laks, Yoshihito Irie, Paul Dempsey^*, Genhong Cheng^*, Michael C. Fishbein and Benjamin Bonavida^1,*

^* Department of Microbiology, Immunology, and Molecular Genetics, Division of Cardiothoracic Surgery, Department of Surgery, and Department of Pathology and Laboratory Medicine, University of California Los Angeles School of Medicine, Los Angeles, CA 90095; and ^§ Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92121

Chronic rejection remains the major obstacle to long term survival in heart transplant recipients. The cellular and molecular mechanisms that underlie chronic rejection are not known, and their discovery can form the basis of clinical intervention. Several investigators have suggested that the development of chronic rejection in solid organ transplants is dependent on help mediated by CD4⁺ lymphocytes. Importantly, the mechanism through which help is provided has not been fully delineated in transplant rejection. Using a murine heterotopic heart transplant model without immunosuppression, this study defines the functional role of CD4⁺ lymphocytes in chronic rejection. In an MHC class II-mismatched model, we demonstrate that chronic rejection was absolutely contingent on the presence of CD4⁺ lymphocytes. Importantly, here we report that signaling through CD40 can replace the requirement of CD4⁺ lymphocytes, demonstrated by the development of chronic rejection in CD4 knockout recipients treated with a CD40-activating mAb (FGK45). The return of rejection appears to be a CD8⁺ lymphocyte-dependent process, noted by the absence of rejection in FGK45-treated recombinase-activated gene knockout (CD4⁺ and CD8⁺ lymphocyte-deficient) recipients. The CD40 signaling pathway works independently of B7-CD28 costimulation, as indicated by the development of severe chronic rejection in CD28 knockout recipients. Importantly, this study provides evidence that CD40 ligand-targeted therapies may prevent chronic rejection only in strain combinations where CD4⁺ lymphocyte help is absolutely required.

This article has been cited by other articles:

				M. Isobe, H. Kosuge, and J.-i. Suzuki T Cell Costimulation in the Development of Cardiac Allograft Vasculopathy: Potential Targets for Therapeutic Interventions Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1447 - 1456. [Abstract] [Full Text] [PDF]

				D. M. Lindell, T. A. Moore, R. A. McDonald, G. B. Toews, and G. B. Huffnagle Generation of Antifungal Effector CD8+ T Cells in the Absence of CD4+ T Cells during Cryptococcus neoformans Infection J. Immunol., June 15, 2005; 174(12): 7920 - 7928. [Abstract] [Full Text] [PDF]

				J. J. Yun, D. Whiting, M. P. Fischbein, A. Banerji, Y. Irie, D. Stein, M. C. Fishbein, A. E.I. Proudfoot, H. Laks, J. A. Berliner, et al. Combined Blockade of the Chemokine Receptors CCR1 and CCR5 Attenuates Chronic Rejection Circulation, February 24, 2004; 109(7): 932 - 937. [Abstract] [Full Text] [PDF]

				T. C. Tung, G. Cui, K. Oshima, H. Laks, and L. Sen Balanced expression of mitochondrial apoptosis regulatory proteins correlates with long-term survival of cardiac allografts Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2832 - H2841. [Abstract] [Full Text] [PDF]

				M. P. Fischbein, J. Yun, H. Laks, Y. Irie, L. Oslund-Pinderski, M. C. Fishbein, B. Bonavida, and A. Ardehali Regulated interleukin-10 expression prevents chronic rejection of transplanted hearts J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 216 - 223. [Abstract] [Full Text] [PDF]

				V. Vezys and L. Lefrancois Cutting Edge: Inflammatory Signals Drive Organ-Specific Autoimmunity to Normally Cross-Tolerizing Endogenous Antigen J. Immunol., December 15, 2002; 169(12): 6677 - 6680. [Abstract] [Full Text] [PDF]

				J. J. Yun, M. P. Fischbein, D. Whiting, Y. Irie, M. C. Fishbein, M. D. Burdick, J. Belperio, R. M. Strieter, H. Laks, J. A. Berliner, et al. The Role of MIG/CXCL9 in Cardiac Allograft Vasculopathy Am. J. Pathol., October 1, 2002; 161(4): 1307 - 1313. [Abstract] [Full Text] [PDF]

				M. P. Fischbein, J. Yun, H. Laks, Y. Irie, M. C. Fishbein, B. Bonavida, and A. Ardehali Role of CD8+ lymphocytes in chronic rejection of transplanted hearts J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 803 - 809. [Abstract] [Full Text] [PDF]